1jco Citations

Flexibility and bioactivity of insulin: an NMR investigation of the solution structure and folding of an unusually flexible human insulin mutant with increased biological activity.

Biochemistry 40 10732-40 (2001)
Cited: 24 times
EuropePMC logo PMID: 11524020

Abstract

The structure and folding of a novel human insulin mutant, [Thr(B27) --> Pro, Pro(B28) --> Thr]insulin (PT insulin), in aqueous solution and in mixtures of water and 2,2,2-trifluoroethanol (TFE) have been studied by NMR spectroscopy. It was found that PT insulin has a highly flexible structure in pure water and is present in at least two different conformations, although with an overall tertiary structure similar to that of native insulin. Furthermore, the native helical structures are poorly defined. Surprisingly, the mutant has a biological activity about 50% higher than native insulin. In contrast, in TFE/water solution the mutant reveals a propensity of forming a well-defined structure at the secondary structure level, similar to monomeric native insulin. Thus, as shown by a detailed determination of the structure from 208 distance restraints and 52 torsion angle restraints by distance geometry, simulated annealing, and restrained energy minimization, the native insulin helices (A2-A7, A13-A19, and B10-B19) as well as the beta-turn (B20-B23) are formed in 35% TFE. However, the amount of tertiary structure is decreased significantly in TFE/water solution. The obtained results suggest that only an overall tertiary fold, as observed for PT insulin in pure water, is necessary for expressing the biological activity of insulin, as long as the molecule is flexible and retains the propensity to form the secondary structure required for its receptor binding. In contrast, a compact secondary structure, as found for native insulin in solution, is unnecessary for the biological activity. A model for the receptor binding of insulin is suggested that relates the increased bioactivity to the enhanced flexibility of the mutant.

Articles - 1jco mentioned but not cited (1)

  1. An Insulin Receptor-Binding Multifunctional Protein from Tamarindus indica L. Presents a Hypoglycemic Effect in a Diet-Induced Type 2 Diabetes-Preclinical Study. Costa I, Lima M, Medeiros A, Bezerra L, Santos P, Serquiz A, Lima M, Oliveira G, Santos E, Maciel B, Monteiro N, Morais AH. Foods 11 2207 (2022)


Articles citing this publication (23)

  1. Study of the insulin dimerization: binding free energy calculations and per-residue free energy decomposition. Zoete V, Meuwly M, Karplus M. Proteins 61 79-93 (2005)
  2. Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3. Rosengren KJ, Lin F, Bathgate RA, Tregear GW, Daly NL, Wade JD, Craik DJ. J Biol Chem 281 5845-5851 (2006)
  3. Insulin assembly damps conformational fluctuations: Raman analysis of amide I linewidths in native states and fibrils. Dong J, Wan Z, Popov M, Carey PR, Weiss MA. J Mol Biol 330 431-442 (2003)
  4. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer. Zoete V, Meuwly M, Karplus M. J Mol Biol 342 913-929 (2004)
  5. Insulin dimer dissociation and unfolding revealed by amide I two-dimensional infrared spectroscopy. Ganim Z, Jones KC, Tokmakoff A. Phys Chem Chem Phys 12 3579-3588 (2010)
  6. Structure of human insulin monomer in water/acetonitrile solution. Bocian W, Sitkowski J, Bednarek E, Tarnowska A, Kawecki R, Kozerski L. J Biomol NMR 40 55-64 (2008)
  7. Importance of individual side chains for the stability of a protein fold: computational alanine scanning of the insulin monomer. Zoete V, Meuwly M. J Comput Chem 27 1843-1857 (2006)
  8. NMR structure of biosynthetic engineered human insulin monomer B31(Lys)-B32(Arg) in water/acetonitrile solution. Comparison with the solution structure of native human insulin monomer. Bocian W, Borowicz P, Mikołajczyk J, Sitkowski J, Tarnowska A, Bednarek E, Głabski T, Tejchman-Małecka B, Bogiel M, Kozerski L. Biopolymers 89 820-830 (2008)
  9. Non-equivalent role of inter- and intramolecular hydrogen bonds in the insulin dimer interface. Antolíková E, Žáková L, Turkenburg JP, Watson CJ, Hančlová I, Šanda M, Cooper A, Kraus T, Brzozowski AM, Jiráček J. J Biol Chem 286 36968-36977 (2011)
  10. Development of liposomal immunosensor for the measurement of insulin with femtomole detection. Ho JA, Zeng SC, Huang MR, Kuo HY. Anal Chim Acta 556 127-132 (2006)
  11. Chemometric Methods to Quantify 1D and 2D NMR Spectral Differences Among Similar Protein Therapeutics. Chen K, Park J, Li F, Patil SM, Keire DA. AAPS PharmSciTech 19 1011-1019 (2018)
  12. Dual electrochemical determination of glucose and insulin using enzyme and ferrocene microcapsules. Viswanathan S, Ho JA. Biosens Bioelectron 22 1147-1153 (2007)
  13. Novel recombinant insulin analogue with flexible C-terminus in B chain. NMR structure of biosynthetic engineered A22G-B31K-B32R human insulin monomer in water/acetonitrile solution. Borowicz P, Bocian W, Sitkowski J, Bednarek E, Mikiewicz-Syguła D, Błażej-Sosnowska S, Bogiel M, Rusek D, Kurzynoga D, Kozerski L. Int J Biol Macromol 49 548-554 (2011)
  14. Adsorption of human insulin on single-crystal gold surfaces investigated by in situ scanning tunnelling microscopy and electrochemistry. Welinder AC, Zhang J, Steensgaard DB, Ulstrup J. Phys Chem Chem Phys 12 9999-10011 (2010)
  15. Structure-based stabilization of insulin as a therapeutic protein assembly via enhanced aromatic-aromatic interactions. Rege NK, Wickramasinghe NP, Tustan AN, Phillips NFB, Yee VC, Ismail-Beigi F, Weiss MA. J Biol Chem 293 10895-10910 (2018)
  16. Backbone dynamics of TFE-induced native-like fold of region 4 of Escherichia coli RNA polymerase sigma70 subunit. Kaczka P, Polkowska-Nowakowska A, Bolewska K, Zhukov I, Poznański J, Wierzchowski KL. Proteins 78 754-768 (2010)
  17. Insulin Dissociates by Diverse Mechanisms of Coupled Unfolding and Unbinding. Antoszewski A, Feng CJ, Vani BP, Thiede EH, Hong L, Weare J, Tokmakoff A, Dinner AR. J Phys Chem B 124 5571-5587 (2020)
  18. Solution structure of a conformationally restricted fully active derivative of the human relaxin-like factor. Büllesbach EE, Hass MA, Jensen MR, Hansen DF, Kristensen SM, Schwabe C, Led JJ. Biochemistry 47 13308-13317 (2008)
  19. Evaluating the intrinsic cysteine redox-dependent states of the A-chain of human insulin using NMR spectroscopy, quantum chemical calculations, and mass spectrometry. Sharma AK, Ling Y, Greer AB, Hafler DA, Kent SC, Zhang Y, Rigby AC. J Phys Chem B 114 585-591 (2010)
  20. Evidence of oligomerization of bovine insulin in solution given by NMR. Efimov SV, Zgadzay YO, Tarasova NB, Klochkov VV. Eur Biophys J 47 881-889 (2018)
  21. Structural Ensemble of the Insulin Monomer. Busto-Moner L, Feng CJ, Antoszewski A, Tokmakoff A, Dinner AR. Biochemistry 60 3125-3136 (2021)
  22. Computational IR Spectroscopy of Insulin Dimer Structure and Conformational Heterogeneity. Feng CJ, Sinitskiy A, Pande V, Tokmakoff A. J Phys Chem B 125 4620-4633 (2021)
  23. Identifying signatures of proteolytic stability and monomeric propensity in O-glycosylated insulin using molecular simulation. Hsu WT, Ramirez DA, Sammakia T, Tan Z, Shirts MR. J Comput Aided Mol Des 36 313-328 (2022)